IGG4-RD

Clinical trials for IGG4-RD explained in plain language.

Never miss a new study

Get alerted when new IGG4-RD trials appear

Sign up with your email to follow new studies for IGG4-RD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

New drug hope for rare autoimmune disease fizzles in early trial

Disease control Terminated

This study tested the drug elotuzumab for people with active IgG4-related disease (IgG4-RD), a rare condition where the body attacks its own tissues. The trial aimed to see if adding elotuzumab to standard steroid treatment was safe and effective. Only 8 people enrolled before th…

Matched conditions: IGG4-RD

Phase: PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control

Last updated May 17, 2026 06:48 UTC

IGG4-RD

Get alerted when new IGG4-RD trials appear

New drug hope for rare autoimmune disease fizzles in early trial